Suraksha Diagnostic's Quality Grade Upgraded Amid Strong Financial Metrics and Growth Potential

Suraksha Diagnostic, a small-cap player in the healthcare services industry, has recently undergone an adjustment in its evaluation, reflecting a change in its quality grade from average to good. This revision highlights the company's robust financial metrics, particularly its impressive EBIT growth over the past five years, which stands at 89.29%. Additionally, Suraksha Diagnostic has maintained a favorable debt profile, characterized by negative net debt and a debt-to-EBITDA ratio that indicates a strong capacity to manage its obligations.
The company's sales growth over the same five-year period is recorded at 14.50%, showcasing its ability to expand its market presence. Furthermore, the tax ratio is reported at 23.76%, and the return on equity (ROE) averages 12.29%, suggesting effective utilization of equity capital. Institutional holdings are also notable at 36.32%, indicating a level of confidence from larger investors.

Despite a flat financial performance in the recent quarter, Suraksha Diagnostic's operational metrics and overall financial health contribute to its revised evaluation.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.